{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T12:59:21Z","timestamp":1758891561467},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004009","name":"Iwadare Scholarship Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.jphs.2017.05.006","type":"journal-article","created":{"date-parts":[[2017,6,4]],"date-time":"2017-06-04T04:17:41Z","timestamp":1496549861000},"page":"108-115","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) and meso -2,3-dimercaptosuccinic acid (DMSA) on the nephrotoxicity in the mouse during repeated cisplatin (CDDP) treatments"],"prefix":"10.1016","volume":"134","author":[{"given":"Yuka","family":"Yajima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanobu","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Migiwa","family":"Okubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Tsukagoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Katakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2017.05.006_bib1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ijc.2910060207","article-title":"Inhibitory effects of anti-tumor platinum compounds on DNA, RNA and protein synthesis in mammalian cells in\u00a0vitro","volume":"15","author":"Harder","year":"1970","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jphs.2017.05.006_bib2","doi-asserted-by":"crossref","first-page":"803","DOI":"10.7326\/0003-4819-86-6-803","article-title":"Cis-diamminedichloroplatinum (II). A new anticancer drug","volume":"86","author":"Rozencweig","year":"1977","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jphs.2017.05.006_bib3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJM197902083000605","article-title":"The role of cis-platinum in solid-tumor therapy","volume":"300","author":"Einhorn","year":"1979","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jphs.2017.05.006_bib4","first-page":"1663","article-title":"Cisplatin and platinum drugs at the molecular level. (Review)","volume":"10","author":"Boulikas","year":"2003","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jphs.2017.05.006_bib5","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0270-9295(03)00089-5","article-title":"Cisplatin nephrotoxicity","volume":"23","author":"Arany","year":"2003","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.jphs.2017.05.006_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080850","article-title":"5-Aminolevulinic acid protects against cisplatin-induced nephrotoxicity without compromising the anticancer efficiency of cisplatin in rats in\u00a0vitro and in\u00a0vivo","volume":"8","author":"Terada","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jphs.2017.05.006_bib7","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1681\/ASN.V134858","article-title":"Cisplatin induces apoptosis in LLCPK1 cells via activation of mitochondrial pathways","volume":"13","author":"Park","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jphs.2017.05.006_bib8","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1046\/j.1523-1755.2001.00026.x","article-title":"Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells","volume":"60","author":"Kaushal","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.jphs.2017.05.006_bib9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0022-2143(99)90106-3","article-title":"Attenuation of cisplatin-induced acute renal failure is associated with less apoptotic cell death","volume":"134","author":"Zhou","year":"1999","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.jphs.2017.05.006_bib10","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.bcp.2005.09.020","article-title":"Association between tubular toxicity of cisplatin and expression of organic cation transporter rOCT2 (Slc22a2) in the rat","volume":"70","author":"Yonezawa","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jphs.2017.05.006_bib11","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/S0002-9440(10)61234-5","article-title":"Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2","volume":"167","author":"Ciarimboli","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jphs.2017.05.006_bib12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1208\/s12248-013-9465-7","article-title":"Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidney","volume":"15","author":"Motohashi","year":"2013","journal-title":"AAPS J"},{"key":"10.1016\/j.jphs.2017.05.006_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2133\/dmpk.23.243","article-title":"Organic cation transporters and their pharmacokinetic and pharmacodynamic consequences","volume":"23","author":"Choi","year":"2008","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.jphs.2017.05.006_bib14","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/j.1476-5381.2011.01394.x","article-title":"Importance of the multidrug and toxin extrusion MATE\/SLC47A family to pharmacokinetics, pharmacodynamics\/toxicodynamics and pharmacogenomics","volume":"164","author":"Yonezawa","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jphs.2017.05.006_bib15","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1046\/j.1523-1755.2000.00251.x","article-title":"Cellular and molecular aspects of drug transport in the kidney","volume":"58","author":"Inui","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.jphs.2017.05.006_bib16","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1124\/dmd.106.010876","article-title":"Molecular identification and functional characterization of rat multidrug and toxin extrusion type transporter 1 as an organic cation\/H+ antiporter in the kidney","volume":"34","author":"Ohta","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jphs.2017.05.006_bib17","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1007\/s11095-006-9016-3","article-title":"Molecular cloning, functional characterization and tissue distribution of rat H+\/organic cation antiporter MATE1","volume":"23","author":"Terada","year":"2006","journal-title":"Pharm Res"},{"key":"10.1016\/j.jphs.2017.05.006_bib18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0041-008X(81)90464-6","article-title":"Thiamin (vitamin b1) effects on lead intoxication and deposition of lead in tissues: therapeutic potential","volume":"59","author":"Bratton","year":"1981","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jphs.2017.05.006_bib19","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1021\/tx049904e","article-title":"Mercury binding to the chelation therapy agents DMSA and DMPS and the rational design of custom chelators for mercury","volume":"17","author":"George","year":"2004","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.jphs.2017.05.006_bib20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1124\/jpet.107.130708","article-title":"Multidrug resistance proteins and the renal elimination of inorganic mercury mediated by 2,3-dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid","volume":"324","author":"Bridges","year":"2008","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jphs.2017.05.006_bib21","first-page":"581","article-title":"The relative effectiveness of some chelating agents as antidotes in acute cadmium poisoning","volume":"22","author":"Jones","year":"1978","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.1016\/j.jphs.2017.05.006_bib22","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0041-008X(81)90098-3","article-title":"Comparison of the effectiveness of several chelators after single administration on the toxicity, excretion, and distribution of cadmium","volume":"58","author":"Cantilena","year":"1981","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jphs.2017.05.006_bib23","first-page":"571","article-title":"The relative effectiveness of some chelating agents in acute copper intoxication in the mouse","volume":"27","author":"Jones","year":"1980","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.1016\/j.jphs.2017.05.006_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1254\/jphs.09323FP","article-title":"Paradoxical effect of 2,3-dimercapto-1-propanesulfonic acid (DMPS) on enhancing antitumor activity of cisplatin in ascites sarcoma 180 cells","volume":"112","author":"Sato","year":"2010","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.jphs.2017.05.006_bib25","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1476-5381.1981.tb16800.x","article-title":"The effect of heavy metal chelators on the renal accumulation of platinum after cis-dichlorodiammineplatinum II administration to the rat","volume":"73","author":"Graziano","year":"1981","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jphs.2017.05.006_bib26","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF00265392","article-title":"The effects of dimercaptosuccinic acid and other chelating agents on the retention of platinum in the rat kidney after treatment with cisplatin","volume":"9","author":"Planas-Bohne","year":"1982","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jphs.2017.05.006_bib27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jat.2550090405","article-title":"Control of nephrotoxicity in the rat during repeated cis-platinum treatments","volume":"9","author":"Jones","year":"1989","journal-title":"J\u00a0Appl Toxicol"},{"key":"10.1016\/j.jphs.2017.05.006_bib28","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3109\/08860229909094153","article-title":"Protection against cis-diamminedichloroplatinum-induced nephrotoxicity by 2,3-dimercaptosuccinic acid in rats","volume":"21","author":"Mishima","year":"1999","journal-title":"Ren Fail"},{"key":"10.1016\/j.jphs.2017.05.006_bib29","first-page":"505","article-title":"Human studies with the chelating agents, DMPS and DMSA","volume":"30","author":"Aposhian","year":"1992","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.jphs.2017.05.006_bib30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-1-4684-0796-9_10","article-title":"Noble metal complexes in cancer chemotherapy","volume":"91","author":"Rosenberg","year":"1977","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jphs.2017.05.006_bib31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0165-1218(79)90021-1","article-title":"Mutagenicity, cytotoxicity and DNA crosslinking in V79 Chinese hamster cells treated with cis- and trans-Pt(II) diamminedichloride","volume":"67","author":"Zwelling","year":"1979","journal-title":"Mutat Res"},{"key":"10.1016\/j.jphs.2017.05.006_bib32","doi-asserted-by":"crossref","first-page":"43377","DOI":"10.1074\/jbc.M206373200","article-title":"Protein kinase C-alpha and ERK1\/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells","volume":"277","author":"Nowak","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jphs.2017.05.006_bib33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1124\/jpet.302.1.8","article-title":"Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways","volume":"302","author":"Cummings","year":"2002","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jphs.2017.05.006_bib34","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0022-2143(98)90060-9","article-title":"The role of oxygen free radicals in cisplatin-induced acute renal failure in rats","volume":"131","author":"Matsushima","year":"1998","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.jphs.2017.05.006_bib35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/10408441003601836","article-title":"The relationship between cisplatin- induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin","volume":"40","author":"Brozovic","year":"2010","journal-title":"Crit Rev Toxicol"},{"key":"10.1016\/j.jphs.2017.05.006_bib36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jphs.2014.11.009","article-title":"Glutamine protects against cisplatin-induced nephrotoxicity by decreasing cisplatin accumulation","volume":"127","author":"Kim","year":"2015","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.jphs.2017.05.006_bib37","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1046\/j.1523-1755.2003.00908.x","article-title":"Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis","volume":"63","author":"Liu","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.jphs.2017.05.006_bib38","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1152\/ajprenal.00101.2003","article-title":"TNFR2-mediated apoptosis and necrosis in cisplatin- induced acute renal failure","volume":"285","author":"Ramesh","year":"2003","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.jphs.2017.05.006_bib39","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.bcp.2007.03.004","article-title":"Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity","volume":"74","author":"Yokoo","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jphs.2017.05.006_bib40","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/sj.bjc.6601719","article-title":"Pharmacokinetic behavior of the chemoprotectants BNP7787 and mesna after an i.v. bolus injection in rats","volume":"90","author":"Verschraagen","year":"2004","journal-title":"Br J Cancer"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861317300804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861317300804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T04:10:03Z","timestamp":1659067803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861317300804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1347861317300804"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2017.05.006","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the nephrotoxicity in the mouse during repeated cisplatin (CDDP) treatments","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2017.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}